Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Frances A. Bromidge"'
Autor:
Wesley Peter Blackaby, George R. Marshall, Richard Thomas Lewis, Simon Charles Goodacre, John R. Atack, David James Hallett, Leslie J. Street, Frances A. Bromidge, Andrew Pike, Alison J. Smith, David F. Tattersall, Keith A. Wafford, José L. Castro
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 16:1175-1179
Imidazo[1,2-a]pyrimidines are GABA(A) receptor benzodiazepine binding site ligands which can exhibit functional selectivity for the alpha(3) subtype over the alpha(1) subtype. SAR studies to optimize this functional selectivity are described.
Autor:
Sally A. Thompson, Leslie J. Street, Bindi Sohal, George R. Marshall, Susan M. Cook, Ruth M. McKernan, Guy R. Seabrook, Keith A. Wafford, Andrew Pike, John R. Atack, Gerard R. Dawson, Richard Alexander Jelley, Goplan V. Pillai, Francine Sternfeld, Kevin W. Moore, Frances A. Bromidge, José L. Castro, Angus Murray Macleod, Austin John Reeve, Robert W. Carling
Publikováno v:
Journal of Medicinal Chemistry. 47:3642-3657
The identification of a novel series of 7,8,9,10-tetrahydro-(7,10-ethano)-1,2,4-triazolo[3,4-a]phthalazines as GABA(A)alpha5 inverse agonists, which have both binding and functional (efficacy) selectivity for the benzodiazepine binding site of alpha5
Autor:
Paul J. Whiting, Frances A. Bromidge, Thomas W. Rosahl, David S. Reynolds, Robert J. Newman, John R. Atack, G. R. Dawson, Gillian F. O'Meara
Publikováno v:
Neuropharmacology. 44:190-198
The GABA(A) receptor system provides the major inhibitory control in the CNS, with the alpha 1 beta 2 gamma 2 subunit combination being the most abundant and widely distributed form of the receptor. The alpha1 subunit knock-out (alpha1 KO) mice had a
Autor:
Paul J. Whiting, M. Anna Casula, Peter B. Wingrove, Frances A. Bromidge, Karen A. Maubach, Karine Martin, Guy R. Seabrook, K. L. Hadingham, Gopalan V. Pillai
Publikováno v:
Journal of Neurochemistry. 77:445-451
L-655,708 is a ligand for the benzodiazepine site of the γ-aminobutyric acid type A (GABAA) receptor that exhibits a 100-fold higher affinity for α5-containing receptors compared with α1-containing receptors. Molecular biology approaches have been
Autor:
Robert W. Carling, Elena Mezzogori, Spencer J. Tye, Rebecca Dias, Rachael Lincoln, Alison J. Smith, María Domínguez, Keith A. Wafford, Frances A. Bromidge, Simon Charles Goodacre, Susan M. Cook, Robert J. Newman, Andrew Pike, David James Hallett, Atack, Michael G. N. Russell, Wayne F. A. Sheppard, Pushpinder Ferris, Michael Reader, Leslie J. Street, George R. Marshall, Bindi Sohal, Joanna Stanley, Castro Jl, David S. Reynolds
Publikováno v:
Journal of medicinal chemistry. 49(4)
The identification of a series of imidazo[1,2-b][1,2,4]triazines with high affinity and functional selectivity for the GABA(A) alpha3-containing receptor subtype is described, leading to the identification of a clinical candidate, 11. Compound 11 sho
Autor:
Wesley Peter Blackaby, Frances A. Bromidge, Ruth M. McKernan, Michael G. N. Russell, Keith A. Wafford, John R. Atack, Alison J. Smith, Richard Thomas Lewis, Leslie J. Street, José L. Castro
Publikováno v:
Bioorganicmedicinal chemistry letters. 15(22)
2,5-Dihydro-3H-pyrazolo[4,3-c]pyridin-3-ones are GABAA receptor benzodiazepine binding site ligands, which can exhibit functional selectivity for the α3 subtype over the α1 subtype. SAR studies to optimize this functional selectivity are described.
Autor:
Robert W. Carling, Frances A. Bromidge, Catherine Isted, Alison J. Macaulay, José L. Castro, Peter W. Hunt, Ruth M. McKernan, Andrew Mitchinson, Matt Lucas, David W. Thomas, John R. Atack, Kevin W. Moore, Michael G. N. Russell, Keith A. Wafford, Susan M. Cook, Sally-Anne Thompson, Robert Narquizian
Publikováno v:
Journal of medicinal chemistry. 48(5)
We have previously identified the 7,8,9,10-tetrahydro-7,10-ethano-1,2,4-triazolo[3,4-a]phthalazine (1) as a potent partial agonist for the alpha(3) receptor subtype with 5-fold selectivity in binding affinity over alpha(1). This paper describes a det
Autor:
Shil Patel, George McAllister, Josephine A. Stanton, Andrew Pate Owens, Paul J. Whiting, Martin R. Guscott, Kevin C. F. Fone, Stephany M. Biello, J Myers, Margaret S. Beer, K. L. Hadingham, Janusz Jozef Kulagowski, Frances A. Bromidge, Peter H. Hutson, Ian Thomas Huscroft, Thomas W. Rosahl, Nadia Melanie Rupniak, Linda J. Bristow
Publikováno v:
Neuropharmacology. 48(4)
The affinity of several antidepressant and antipsychotic drugs for the 5-HT7 receptor and its CNS distribution suggest potential in the treatment of psychiatric diseases. However, there is little direct evidence of receptor function in vivo to suppor
Autor:
Ian Collins, John R. Atack, K Quirk, Bindi Sohal, Andrew Pike, Sally-Ann Thompson, Michael Rowley, Gerard R. Dawson, Richard G. Ball, José L. Castro, Christopher Moyes, William B Davey, Frances A. Bromidge, Keith A. Wafford, Nancy N. Tsou, Ruth M. McKernan
Publikováno v:
Journal of medicinal chemistry. 45(9)
A novel series of 3-heteroaryl-5,6-bis(aryl)-1-methyl-2-pyridones were developed with high affinity for the benzodiazepine (BZ) binding site of human gamma-aminobutyric acid (GABA(A)) receptor ion channels, low binding selectivity for alpha 2- and/or
Autor:
Howard B. Broughton, Karen A. Maubach, Angus Murray Macleod, John R. Atack, Keith A. Wafford, Susan M. Cook, Mark Stuart Chambers, Gerard R. Dawson, Frances A. Bromidge, Guy R. Seabrook, Sarah Christine Hobbs, Austin John Reeve
Publikováno v:
Journal of medicinal chemistry. 45(6)
Nonselective inverse agonists at the benzodiazepine binding site on the GABA-A chloride ion channel enhance cognitive performance in animals but cannot be used in the treatment of cognitive disorders because of anxiogenic and convulsant side effects.